S. Pocock

发表

Bivalirudin during primary PCI in acute myocardial infarction.

B. Gersh, S. Pocock, G. Stone, 2008, The New England journal of medicine.

Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.

G. Dangas, J. Muhlestein, M. Effron, 2017, The Canadian journal of cardiology.

Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

J. Ware, S. Pocock, H. White, 2007, JAMA.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

D. Kandzari, M. Morice, J. Sabik, 2020, The New England journal of medicine.

Non-proportional Hazards for Time-to-event Outcomes in Clinical Trials: A practical guide to analysis strategies

C. Burman, F. Öhrn, Gregg W. Stone, 2019 .

Bivalirudin for patients with acute coronary syndromes.

Adelaide, J. Ware, S. Pocock, 2006, The New England journal of medicine.

Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.

G. Stone, G. Dangas, J. Moses, 2004, Journal of the American College of Cardiology.

Effect of Early Metoprolol on Infarct Size in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary PCI: The METOCARD-CNIC Trial

C. Macaya, A. Fernández-Ortiz, L. Fernandez-Friera, 2013 .

Effect of Early Metoprolol on Infarct Size in ST-Segment–Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial

P. López-Romero, C. Macaya, A. Fernández-Ortiz, 2013 .

Effects of Icosapent Ethyl on Total Ischemic Events From REDUCE-IT

J. Tardif, C. Ballantyne, E. Brinton, 2019 .

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

B. Gersh, S. Pocock, G. Stone, 2009, The Lancet.

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

B. Gersh, S. Pocock, G. Stone, 2009, The New England journal of medicine.

Prognostic Modeling of Individual Patient Risk and Mortality Impact of Ischemic and Hemorrhagic Complications: Assessment From the Acute Catheterization and Urgent Intervention Triage Strategy Trial

S. Pocock, H. White, E. Ohman, 2010, Circulation.

Coronary angioplasty versus medical therapy for angina. Health service costs based on the second Randomized Intervention Treatment of Angina (RITA-2) trial.

M. Sculpher, M. Buxton, D. Chamberlain, 2002, European heart journal.

A comparison of aspirin and anticoagulation following thrombolysis for myocardial infarction (the AFTER study): a multicentre unblinded randomised clinical trial

S. Pocock, D. Chamberlain, D. Julian, 1996, BMJ.

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

T. Shaw, S. Pocock, Tim C. Clayton, 2002, Lancet.

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

P. Poole‐Wilson, S. Pocock, M. Motro, 2004, The Lancet.

Recurrent Events in Cardiovascular Trials: JACC State-of-the-Art Review.

Deepak L. Bhatt, B. Redfors, C. Zeller, 2023, Journal of the American College of Cardiology.

Prevalence, Vascular Distribution and Multi-territorial Extent of Subclinical Atherosclerosis in a Middle-aged Cohort: the Pesa (progression of Early Subclinical Atherosclerosis) Study Ho Ho Hosp Sp Spit It Ita a a A

E. Guallar, A. Fernández-Ortiz, Agustín Mocoroa, 2022 .

Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial

J. Ware, S. Pocock, H. White, 2007, The Lancet.

Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).

J. Ware, S. Pocock, H. White, 2010, The American journal of cardiology.

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

S. Pocock, T. Henry, M. Krucoff, 2018, Circulation. Cardiovascular interventions.

Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.

S. Pocock, H. White, E. Ohman, 2009, JACC. Cardiovascular interventions.

Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease.

S. Pocock, P. Serruys, G. Stone, 2019, The New England journal of medicine.

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.

T. Povsic, M. Bahit, P. Tricoci, 2024, The New England journal of medicine.

Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding Risk: A Cost Consequence Simulation From PARIS

S. Pocock, T. Henry, M. Krucoff, 2019, Circulation. Cardiovascular quality and outcomes.

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

M. Morice, P. Garot, R. Zambahari, 2015, The New England journal of medicine.